A Study to Investigate the Safety and Immunogenicity of Different Formulations of GSK Biologicals' Meningococcal ACWY Conjugate Vaccine (GSK3536820A and Menveo) Administered to Healthy Adolescents and Young Adults 10 to 40 Years of Age
Clinical trial NCT03433482 · COMPLETED
Trial details
- NCT number
- NCT03433482
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-30
- Primary completion
- 2019-07-26
- Enrollment
- 1707
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.